New York State Common Retirement Fund’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

New York State Common Retirement Fund’s Portfolio SGTX Stock Details SGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11	Closed	–	–	3539
2022 Q2	$0	Sell	11 -512	-98%	-$6.88K	﹤0.01%	3584
2022 Q1	$10K	Sell	523 -10	-2%	-$223	﹤0.01%	3317
2021 Q4	$19K	Buy	533 +4	+0.8%	+$228	﹤0.01%	3302
2021 Q3	$39K	Buy	529 +1	+0.2%	+$77	﹤0.01%	3266
2021 Q2	$74K	Buy	528 +306	+138%	+$53.8K	﹤0.01%	3243
2021 Q1	$65K	Buy	+222	New	+$88.3K	﹤0.01%	3171

Other funds holding SGTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund's SGTX Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2022, closing a stake of 11 shares.

New York State Common Retirement Fund first reported a position in SGTX in Q1 2021 and held it in 6 quarters. The position peaked at $74K in Q2 2021. 33 funds tracked by Wall St. Rank hold SGTX as of Q3 2022.

New York State Common Retirement Fund reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 11 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2022.
New York State Common Retirement Fund first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
New York State Common Retirement Fund's Sigilon Therapeutics, Inc. Common Stock position peaked at $74K in Q2 2021.
33 funds tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.